OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Dawn F. Ionescu, Dong‐Jing Fu, Xin Qiu, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 22-31
Open Access | Times Cited: 337
Dawn F. Ionescu, Dong‐Jing Fu, Xin Qiu, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 22-31
Open Access | Times Cited: 337
Showing 1-25 of 337 citing articles:
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
Roger S. McIntyre, Joshua D. Rosenblat, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 5, pp. 383-399
Open Access | Times Cited: 472
Roger S. McIntyre, Joshua D. Rosenblat, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 5, pp. 383-399
Open Access | Times Cited: 472
Blinding and expectancy confounds in psychedelic randomized controlled trials
Suresh Muthukumaraswamy, Anna Forsyth, Thomas Lumley
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 9, pp. 1133-1152
Closed Access | Times Cited: 209
Suresh Muthukumaraswamy, Anna Forsyth, Thomas Lumley
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 9, pp. 1133-1152
Closed Access | Times Cited: 209
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Tsvetelina Baryakova, Brett H. Pogostin, Róbert Langer, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 5, pp. 387-409
Open Access | Times Cited: 182
Tsvetelina Baryakova, Brett H. Pogostin, Róbert Langer, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 5, pp. 387-409
Open Access | Times Cited: 182
Ketamine treatment for depression: a review
Mani Yavi, Holim Lee, Ioline D. Henter, et al.
Discover Mental Health (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 85
Mani Yavi, Holim Lee, Ioline D. Henter, et al.
Discover Mental Health (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 85
New and emerging approaches to treat psychiatric disorders
Katherine W. Scangos, Matthew W. State, Andrew H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 317-333
Closed Access | Times Cited: 72
Katherine W. Scangos, Matthew W. State, Andrew H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 317-333
Closed Access | Times Cited: 72
Long-term safety of ketamine and esketamine in treatment of depression
Sina Nikayin, Eva Murphy, John H. Krystal, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 777-787
Closed Access | Times Cited: 70
Sina Nikayin, Eva Murphy, John H. Krystal, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 777-787
Closed Access | Times Cited: 70
Ketamine for the treatment of major depression: a systematic review and meta-analysis
Stevan Nikolin, Anthony Rodgers, Andreas Schwaab, et al.
EClinicalMedicine (2023) Vol. 62, pp. 102127-102127
Open Access | Times Cited: 64
Stevan Nikolin, Anthony Rodgers, Andreas Schwaab, et al.
EClinicalMedicine (2023) Vol. 62, pp. 102127-102127
Open Access | Times Cited: 64
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 48
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 48
Esketamine for treatment‑resistant depression: A review of clinical evidence (Review)
Octavian Vasiliu
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 3
Open Access | Times Cited: 45
Octavian Vasiliu
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 3
Open Access | Times Cited: 45
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Konstantinos Ν. Fountoulakis, Athanasios Saitis, Alan F. Schatzberg
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 6
Konstantinos Ν. Fountoulakis, Athanasios Saitis, Alan F. Schatzberg
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 6
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
Rebecca Dean, Cristina Hurducas, Keith Hawton, et al.
Cochrane library (2021) Vol. 2021, Iss. 11
Open Access | Times Cited: 74
Rebecca Dean, Cristina Hurducas, Keith Hawton, et al.
Cochrane library (2021) Vol. 2021, Iss. 11
Open Access | Times Cited: 74
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1084-1117
Open Access | Times Cited: 70
Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1084-1117
Open Access | Times Cited: 70
Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium
Gustavo Vázquez, Anees Bahji, Juan Undurraga, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 8, pp. 890-900
Open Access | Times Cited: 67
Gustavo Vázquez, Anees Bahji, Juan Undurraga, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 8, pp. 890-900
Open Access | Times Cited: 67
Novel Pharmacological Approaches to the Treatment of Depression
Elias Elias, Ariel Y. Zhang, Melissa T. Manners
Life (2022) Vol. 12, Iss. 2, pp. 196-196
Open Access | Times Cited: 48
Elias Elias, Ariel Y. Zhang, Melissa T. Manners
Life (2022) Vol. 12, Iss. 2, pp. 196-196
Open Access | Times Cited: 48
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression
Guang Chen, Li Chen, Yun Zhang, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 4, pp. 269-279
Open Access | Times Cited: 42
Guang Chen, Li Chen, Yun Zhang, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 4, pp. 269-279
Open Access | Times Cited: 42
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Anees Bahji, Carlos A. Zarate, Gustavo Vázquez
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 853-866
Open Access | Times Cited: 40
Anees Bahji, Carlos A. Zarate, Gustavo Vázquez
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 853-866
Open Access | Times Cited: 40
Reporting of harms in clinical trials of esketamine in depression: a systematic review
Tanguy Taillefer de Laportalière, Adeline Jullien, Antoine Yrondi, et al.
Psychological Medicine (2023) Vol. 53, Iss. 10, pp. 4305-4315
Closed Access | Times Cited: 35
Tanguy Taillefer de Laportalière, Adeline Jullien, Antoine Yrondi, et al.
Psychological Medicine (2023) Vol. 53, Iss. 10, pp. 4305-4315
Closed Access | Times Cited: 35
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
Fabrice Jollant, Romain Colle, Thi Mai Loan Nguyen, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 33
Fabrice Jollant, Romain Colle, Thi Mai Loan Nguyen, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 33
Opioid-Free Versus Opioid-Based Anesthesia on Postoperative Pain After Thoracoscopic Surgery: The Use of Intravenous and Epidural Esketamine
Huan Yan, Wannan Chen, Youwen Chen, et al.
Anesthesia & Analgesia (2023)
Closed Access | Times Cited: 31
Huan Yan, Wannan Chen, Youwen Chen, et al.
Anesthesia & Analgesia (2023)
Closed Access | Times Cited: 31
A Randomized Double-Blind Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation
Tung‐Ping Su, Cheng‐Ta Li, Wei‐Chen Lin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 331-339
Open Access | Times Cited: 25
Tung‐Ping Su, Cheng‐Ta Li, Wei‐Chen Lin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 331-339
Open Access | Times Cited: 25
The HPA Axis as Target for Depression
Andreas Menke
Current Neuropharmacology (2023) Vol. 22, Iss. 5, pp. 904-915
Open Access | Times Cited: 24
Andreas Menke
Current Neuropharmacology (2023) Vol. 22, Iss. 5, pp. 904-915
Open Access | Times Cited: 24
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
Giacomo d’Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 314-322
Closed Access | Times Cited: 24
Giacomo d’Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 314-322
Closed Access | Times Cited: 24
Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis
Alexandros Matsingos, Marcel Wilhelm, Laila Noor, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 10
Alexandros Matsingos, Marcel Wilhelm, Laila Noor, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 10
Esketamine Nasal Spray in Major Depressive Disorder: A Meta‐Analysis of Randomized Controlled Trials
Zhibin Wang, Lili Jiang, Wei Ma, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Zhibin Wang, Lili Jiang, Wei Ma, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Making Progress in Clinical Trials for Suicide Prevention
Samuel T. Wilkinson, Craig J. Bryan, Larry Alphs, et al.
JAMA Psychiatry (2025)
Closed Access | Times Cited: 1
Samuel T. Wilkinson, Craig J. Bryan, Larry Alphs, et al.
JAMA Psychiatry (2025)
Closed Access | Times Cited: 1
